BioCentury
ARTICLE | Financial News

Emmaus pulls IPO

July 27, 2013 12:43 AM UTC

Emmaus Life Sciences Inc. (Torrance, Calif.) withdrew its plans for an IPO about two years after the company first proposed the offering. Emmaus did not provide a reason in its SEC filing and could not be reached for comment. Aegis Capital was underwriter. Emmaus markets NutreStore, an L-glutamine powder for oral solution, to treat short bowel syndrome. Since last year, the company has been in a court battle with AFH Holding & Advisory, which was acting as financial advisor to Emmaus. AFH filed a complaint last September alleging that Emmaus refused to fully reimburse AFH for incurred expenses. ...